Optimizing hormone therapy in localized prostate cancer: Focus on external beam radiotherapy

Journal of Urology

Volumn 172, Issue 5 II, 2004, Pages

  Sandler, Howard M ^a,b   Smith, Matthew R ^b   Nelson, Joel B ^b   Kantoff, Philip W ^b   D'Amico, Anthony V ^b   Klotz, Laurence ^b   Carroll, Peter R ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Department of Radiation Oncology ^*

Author keywords

Androgen antagonists; Prostate; Prostatic neoplasms; Radiotherapy

Indexed keywords

ANDROGEN; CYPROTERONE ACETATE; GOSERELIN;

CANCER GRADING; CANCER HORMONE THERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; HIGH RISK PATIENT; HUMAN; LONG TERM CARE; MALE; PELVIS LYMPH NODE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION BEAM; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 78649377771     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000141682.27320.c6     Document Type: Conference Paper

References (15)

1. Symon, Z., Griffith, K. A., McLaughlin, P. W., Sullivan, M. and Sandler, H. M.: Dose escalation for localized prostate cancer: substantial benefit observed with 3D conformal therapy. Int J Radiat Oncol Biol Phys, 57: 384, 2003
2. Pollack, A., Zagars, G. K., Starkschall, G., Antolak, J. A., Lee, J. J., Huang, E. et al: Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys, 53: 1097, 2002
3. Wei, J. T., Dunn, R. L., Sandler, H. M., McLaughlin, P. W. Montie, J. E., Litwin, M. S. et al: Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol, 20: 557, 2002
4. Alcini, E., D'Addessi, A., Destito, A. and Grasso, G.: LH-RH analogue treatment for advanced prostate cancer. Am J Clin Oncol, suppl., 2: S120, 1988
5. Zietman, A. L., Prince, E. A., Nakfoor, B. M. and Park, J. J.: Androgen deprivation and radiation therapy: sequencing studies using the Shionogi in vivo tumor system. Int J Radiat Oncol Biol Phys, 38: 1067, 1997
6. Gleave, M. E., Goldenberg, S. L., Chin, J. L., Warner, J., Saad, F., Klotz, L. H. and the Canadian Uro-Oncology Group: Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects. J Urol, 166: 500, 2001
7. Zelefsky, M. J. and Harrison, A.: Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: reducing the potential morbidity of therapy. Urology, suppl., 49: 38, 1997
8. Pilepich, M. V., Winter, K., John, M. J., Mesic, J. B., Sause, W., Rubin, P. et al: Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys, 50: 1243, 2001
9. Roach, M., 3rd., DeSilvio, M., Lawton, C., Uhl, V., Machtay, M., Seider, M. J. and the Radiation Therapy Oncology Group 9413: Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol, 21: 1904, 2003
10. Bolla, M., Collette, L., Blank, L., Warde, P., Dubois, J. B., Mirimanoff, R. O. et al: Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet, 360: 103, 2002
11. Pilepich, M. V., Winter, K., Lawton, C., Krisch, R. E., Wolkov, H., Movsas, B. et al: Androgen suppression adjuvant to radiotherapy in carcinoma of the prostate, long-term results of phase III RTOG study 85-31. Int J Radiat Oncol Biol Phys, suppl., 57: S172, 2003
12. Hanks, G. E., Pajak, T. F., Porter, A., Grignon, D., Brereton, H., Venkatesan, V. et al: Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02. J Clin Oncol, 21: 3972, 2003
13. D'Amico, A. V., Schultz, D., Loffredo, M., Dugal, R., Hurwitz, M., Kaplan, I. et al: Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer. JAMA, 284: 1280, 2000
14. Klotz, L. H., Goldenberg, S. L., Jewett, M. A., Fradet, Y., Nam, R., Barkin, J. et al: Long-term followup of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy. J Urol, 170: 791, 2003
15. Gleave, M. E., Goldenberg, L., Chin, J. L., Warner, J., Saad, F., Klotz, L. et al: Randomized comparative study of 3 vs 8 months of neoadjuvant hormonal therapy prior to radical prostatectomy: 3 year PSA recurrence rates. J Urol, 169: 179, 2003